ES2090341T3 - 1-alcoholes de prostaglandina (pgf) y sus usos como hipotensivos oculares. - Google Patents
1-alcoholes de prostaglandina (pgf) y sus usos como hipotensivos oculares.Info
- Publication number
- ES2090341T3 ES2090341T3 ES91912254T ES91912254T ES2090341T3 ES 2090341 T3 ES2090341 T3 ES 2090341T3 ES 91912254 T ES91912254 T ES 91912254T ES 91912254 T ES91912254 T ES 91912254T ES 2090341 T3 ES2090341 T3 ES 2090341T3
- Authority
- ES
- Spain
- Prior art keywords
- configuration
- alpha
- independently
- indicate
- pgf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
LA INVENCION SE REFIERE AL USO DE DERIVADOS DE PROSTAGLANDINAS TIPO F DE ALCOHOLES QUE ACTUAN COMO HIPOTENSORES OCULARES. LOS DERIVADOS DE PGF UTILIZADOS SEGUN LA INVENCION QUEDAN REPRESENTADOS POR LA FORMULA ESTRUCTURA (I) EN DONDE LOS ENLACES CON LINEAS ONDULADAS INDICAN BIEN LA CONFIGURACION ALFA (O) O LA BETA ((BETA)); LAS LINEAS RAYADAS INDICAN UNA CONFIGURACION O, LOS TRIANGULOS CON UNA LINEA GRUESA SE UTILIZAN PARA INDICAR UNA CONFIGURACION (BETA), LOS ENLACES CON GUIONES REPRESENTAN UN ENLACE DOBLE, EL ENLACE DOBLE DE LAS POSICIONES 5,6 TIENE UNA CONFIGURACION CIS, O ES UN ENLACE SENCILLO; R ES HIDROGENO O UN GRUPO -(CO)R4; R1, R2 Y R3 SON INDEPENDIENTEMENTE HIDROXILO O GRUPOS -O(CO)R5, EN DONDE R4 Y R5 REPRESENTAN INDEPENDIENTEMENTE UN HIDROCARBURO ACICLICO SATURADO O NO SATURADO QUE TIENE DE 1 A 20 ATOMOS DE CARBONO O -(CH2)NR6 DONDE N ES DE 0 A 10 Y R6 ES UN ANILLO ALIFATICO, AROMATICO O HETEROAROMATICO, R7 Y R8 SON INDEPENDIENTEMENTE HIDROGENO O ALKILO DE UNO A 6 ATOMOS DE CARBONO O LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/538,204 US5238961A (en) | 1990-06-14 | 1990-06-14 | Pgf 1-alcohols and their use as ocular hypotensives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2090341T3 true ES2090341T3 (es) | 1996-10-16 |
Family
ID=24145936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91912254T Expired - Lifetime ES2090341T3 (es) | 1990-06-14 | 1991-06-11 | 1-alcoholes de prostaglandina (pgf) y sus usos como hipotensivos oculares. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5238961A (es) |
EP (1) | EP0533828B1 (es) |
JP (1) | JP3139766B2 (es) |
KR (1) | KR100196769B1 (es) |
AT (1) | ATE141163T1 (es) |
AU (1) | AU638587B2 (es) |
BR (1) | BR9106549A (es) |
CA (1) | CA2084769A1 (es) |
DE (1) | DE69121408T2 (es) |
ES (1) | ES2090341T3 (es) |
HU (1) | HUT63371A (es) |
IE (1) | IE912011A1 (es) |
WO (1) | WO1991019490A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270049A (en) * | 1990-11-09 | 1993-12-14 | Allergan, Inc. | 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
US5139491A (en) * | 1990-12-06 | 1992-08-18 | Allergan, Inc. | 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives |
IE920397A1 (en) * | 1991-02-07 | 1992-08-12 | Allergan Inc | 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f¹derivatives |
US5312832A (en) * | 1991-05-17 | 1994-05-17 | Allergan, Inc. | Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US6124353A (en) * | 1992-11-12 | 2000-09-26 | Allergan Sales, Inc. | Method of treating ocular hypertension with 8-epi prostaglandins |
US5476872A (en) * | 1993-10-18 | 1995-12-19 | Allergan, Inc. | 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1 |
US5545665A (en) * | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
US6441047B2 (en) | 1995-11-17 | 2002-08-27 | Alcon Manufacturing Ltd.. | Combination therapy for treating glaucoma |
AU729318B2 (en) * | 1996-05-28 | 2001-02-01 | Allergan, Inc. | Cyclopentan(en)e heptenoic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
US6770675B2 (en) | 1997-03-17 | 2004-08-03 | Novartis Ag | Compositions and methods for reducing ocular hypertension |
WO2001055102A1 (fr) * | 2000-01-28 | 2001-08-02 | Asahi Glass Company, Limited | Nouveau derive difluoroprostaglandine |
US6414021B1 (en) * | 2000-08-25 | 2002-07-02 | Sucampo Ag | Control of intraocular pressure during surgery |
US20040216749A1 (en) * | 2003-01-23 | 2004-11-04 | Hosheng Tu | Vasomodulation during glaucoma surgery |
US20040151691A1 (en) | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
US6949518B1 (en) | 2003-06-25 | 2005-09-27 | Pao-Hsien Chu | Methods for treating macular degeneration with topiramate |
US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4055593A (en) * | 1971-02-19 | 1977-10-25 | Alza Corporation | Alkyl diethers of prostaglandins |
US3940438A (en) * | 1971-05-24 | 1976-02-24 | Alza Corporation | Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid |
US3853854A (en) * | 1971-06-24 | 1974-12-10 | Alza Corp | Novel 5{40 ,6{40 -dihydro-2h-pyran-4{40 -yl prostaglandin ethers |
US4001306A (en) * | 1971-12-30 | 1977-01-04 | The Upjohn Company | Prostaglandin F.sub.α 15-monoacrylates |
US3941886A (en) * | 1973-09-21 | 1976-03-02 | Alza Corporation | Pharmaceutical compositions containing crystalline racemic 9α, 11α, 15(S)-trihydroxy-5-cis, 13-trans-prostadienoic acid |
NL7605381A (nl) * | 1975-05-26 | 1976-11-30 | Schering Ag | Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking. |
US4025577A (en) * | 1975-06-12 | 1977-05-24 | Exxon Research And Engineering Company | Hydroalkylation of paraffins with olefins utilizing hydrogen fluoride and metal pentafluoride catalyst |
US4049678A (en) * | 1976-03-29 | 1977-09-20 | The Upjohn Company | 9-Deoxy-PGD-type, 1,15-lactones |
US4016184A (en) * | 1975-09-17 | 1977-04-05 | The Upjohn Company | 9-Deoxy-9,10-didehydro-PGD1 compounds |
US4201873A (en) * | 1975-09-17 | 1980-05-06 | The Upjohn Company | 9-Deoxy-9,10-didehydro-PGD2 analogs |
US4033989A (en) * | 1975-09-17 | 1977-07-05 | The Upjohn Company | 9-Deoxy-PGF2 Analogs |
US4060540A (en) * | 1975-09-18 | 1977-11-29 | American Cyanamid Company | Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates |
GB2048254B (en) * | 1979-04-02 | 1983-05-25 | Upjohn Co | 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives |
US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
US4883819A (en) * | 1986-07-31 | 1989-11-28 | The Trustees Of Columbia University In The City Of New York | Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma |
US4824857A (en) * | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
US4822819A (en) * | 1986-11-07 | 1989-04-18 | Alcon Laboratories, Inc. | Use of trimoprostil and derivatives in glaucoma therapy |
ZA88963B (en) * | 1987-02-27 | 1989-11-29 | Allergan Inc | Prostaglandins useful for lowering intraocular pressure |
ES2042625T5 (es) * | 1987-04-03 | 2000-07-16 | Univ Columbia | Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular. |
SE8703854D0 (sv) * | 1987-10-07 | 1987-10-07 | Pharmacia Ab | Prostaglandinderivat for behandling av glaukom eller okuler hypertension |
US5139491A (en) * | 1990-12-06 | 1992-08-18 | Allergan, Inc. | 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives |
IE920397A1 (en) * | 1991-02-07 | 1992-08-12 | Allergan Inc | 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f¹derivatives |
-
1990
- 1990-06-14 US US07/538,204 patent/US5238961A/en not_active Expired - Lifetime
-
1991
- 1991-06-11 JP JP03511495A patent/JP3139766B2/ja not_active Expired - Fee Related
- 1991-06-11 ES ES91912254T patent/ES2090341T3/es not_active Expired - Lifetime
- 1991-06-11 HU HU923920A patent/HUT63371A/hu unknown
- 1991-06-11 WO PCT/US1991/004103 patent/WO1991019490A1/en active IP Right Grant
- 1991-06-11 AU AU80539/91A patent/AU638587B2/en not_active Ceased
- 1991-06-11 EP EP91912254A patent/EP0533828B1/en not_active Expired - Lifetime
- 1991-06-11 AT AT91912254T patent/ATE141163T1/de not_active IP Right Cessation
- 1991-06-11 BR BR919106549A patent/BR9106549A/pt not_active Application Discontinuation
- 1991-06-11 KR KR1019920703189A patent/KR100196769B1/ko not_active IP Right Cessation
- 1991-06-11 DE DE69121408T patent/DE69121408T2/de not_active Expired - Fee Related
- 1991-06-11 CA CA002084769A patent/CA2084769A1/en not_active Abandoned
- 1991-06-13 IE IE201191A patent/IE912011A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0533828B1 (en) | 1996-08-14 |
HUT63371A (en) | 1993-08-30 |
BR9106549A (pt) | 1993-06-01 |
WO1991019490A1 (en) | 1991-12-26 |
US5238961A (en) | 1993-08-24 |
EP0533828A4 (en) | 1993-08-11 |
AU638587B2 (en) | 1993-07-01 |
JPH05507928A (ja) | 1993-11-11 |
KR100196769B1 (ko) | 1999-06-15 |
ATE141163T1 (de) | 1996-08-15 |
IE912011A1 (en) | 1991-12-18 |
EP0533828A1 (en) | 1993-03-31 |
DE69121408T2 (de) | 1997-02-20 |
JP3139766B2 (ja) | 2001-03-05 |
DE69121408D1 (de) | 1996-09-19 |
CA2084769A1 (en) | 1991-12-15 |
AU8053991A (en) | 1992-01-07 |
HU9203920D0 (en) | 1993-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2090341T3 (es) | 1-alcoholes de prostaglandina (pgf) y sus usos como hipotensivos oculares. | |
DK0410785T3 (da) | 11-Acylprostaglandiner, som reducerer intraokulartryk | |
ES2157593T3 (es) | Derivados de la adenosina heterociclicos sustituidos en n6. | |
ES513109A0 (es) | "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina". | |
ES2130599T3 (es) | Pseudoceramidas. | |
DK57281A (da) | Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf | |
DE69204627D1 (de) | Prostaglandine. | |
ES2062443T3 (es) | Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2046500T3 (es) | Derivado de la histamina, su preparacion y su aplicacion en terapeutica. | |
MX3847E (es) | Procedimiento para la preparacion de delta 15-esteroides | |
YU2692A (sh) | Novi derivati tetrazola i postupak za njihovo pripremanje | |
ES496880A0 (es) | Un procedimiento para la preparacion de derivados de benzofurano. | |
AR247729A1 (es) | Procedimiento para preparar nuevos compuestos antiarritmicos | |
FI812804L (fi) | 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel | |
ES520693A0 (es) | Un procedimiento para la preparacion de derivados de fenilpiperazina. | |
MX9204457A (es) | Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos. | |
SE7701778L (sv) | 2,9-dioxatricyklo /4,3,1,0?723?717/ dekaner och forfarande for framstellning derav | |
BR9107155A (pt) | 2-decarboxil-2-alcoxialquil prostaglandinas como hipotensivos oculares | |
DK613989A (da) | Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning | |
SE8007569L (sv) | Fosningsmedel jemte sett att dermed framstella stabila losningar lempliga for parenteral administration | |
MX9201392A (es) | Derivados de imidazol y procedimiento para su preparacion. | |
ES467519A1 (es) | Un procedimiento de preparacion de acidos furoil- o tenoil- naftiloxialcohilcarboxilicos. | |
ES2088489T3 (es) | Uso de prostaglandina f3alfa como agente ocular hipotensivo. | |
ES465221A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4- ter-buti-3'-clorodifenilamina con actividad antihistaminica. | |
ES2052945T3 (es) | Derivados de la 20,21-dinoreburnamenina sustituidos en 15 con un grupo aminado y sus sales, su procedimiento de preparacion y los productos intermedios asi obtenidos, su aplicacion como medicamentos, y las composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 533828 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 533828 Country of ref document: ES |